Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Biocryst Pharmaceuticals Inc (NASDAQ: BCRX) closed at $7.65 in the last session, down -1.54% from day before closing price of $7.77. In other words, the price has decreased by -$1.54 from its previous closing price. On the day, 1.99 million shares were traded. BCRX stock price reached its highest trading level at $7.89 during the session, while it also had its lowest trading level at $7.61.
Ratios:
We take a closer look at BCRX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 103.61. For the most recent quarter (mrq), Quick Ratio is recorded 2.22 and its Current Ratio is at 2.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 29, 2025, initiated with a Overweight rating and assigned the stock a target price of $20.
On February 25, 2025, Wedbush started tracking the stock assigning a Outperform rating and target price of $15.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 13 ’25 when HEGGIE THERESA sold 70,000 shares for $8.51 per share. The transaction valued at 595,868 led to the insider holds 65,352 shares of the business.
HEGGIE THERESA bought 70,000 shares of BCRX for $595,871 on Aug 13 ’25. On Dec 13 ’24, another insider, Hutson Nancy J, who serves as the Director of the company, sold 7,000 shares for $7.54 each. As a result, the insider received 52,780 and left with 86,638 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCRX now has a Market Capitalization of 1605891328 and an Enterprise Value of 2084770304. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.88. Its current Enterprise Value per Revenue stands at 3.739 whereas that against EBITDA is 35.633.
Stock Price History:
The Beta on a monthly basis for BCRX is 1.06, which has changed by 0.003937006 over the last 52 weeks, in comparison to a change of 0.15101504 over the same period for the S&P500. Over the past 52 weeks, BCRX has reached a high of $11.31, while it has fallen to a 52-week low of $6.01. The 50-Day Moving Average of the stock is -7.31%, while the 200-Day Moving Average is calculated to be -10.05%.
Shares Statistics:
According to the various share statistics, BCRX traded on average about 3.07M shares per day over the past 3-months and 2908760 shares per day over the past 10 days. A total of 209.91M shares are outstanding, with a floating share count of 202.70M. Insiders hold about 3.44% of the company’s shares, while institutions hold 99.35% stake in the company. Shares short for BCRX as of 1756425600 were 27481907 with a Short Ratio of 9.22, compared to 1753920000 on 25882676. Therefore, it implies a Short% of Shares Outstanding of 27481907 and a Short% of Float of 13.139999999999999.
